Literature DB >> 12032381

Is luteinizing hormone needed for optimal ovulation induction?

Juan Balasch1, Francisco Fábregues.   

Abstract

The role of luteinizing hormone in the natural menstrual cycle is not disputed. There are, however, a variety of opinions regarding the potential role of exogenous luteinizing hormone in ovulation induction and whether it is actually needed. The recent introduction into clinical practice of recombinant gonadotropins has been paralleled by recent advances in the knowledge of the endocrine and paracrine mechanisms that regulate human folliculogenesis. On this basis, this review analyses whether or not all patients need luteinizing hormone for follicular growth stimulation. In addition, new opportunities for improved treatment are considered as a result of the availability of recombinant human luteinizing hormone both in patients with ovulatory disorders and those undergoing multiple follicular development for assisted reproduction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032381     DOI: 10.1097/00001703-200206000-00004

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  12 in total

Review 1.  The role of luteinizing hormone activity in controlled ovarian stimulation.

Authors:  N Angelopoulos; A Goula; G Tolis
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

2.  [Effects of luteinizing hormone supplementation on outcomes of in vitro fertilization and embryo transfer in patients undergoing GnRH-agonist long protocol].

Authors:  Yu Deng; Min-Na Yin; Pei-Ling Liang; Zhi-Heng Chen; Ling Sun
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

3.  Effects of urinary and recombinant gonadotropins on in vitro maturation outcomes of mouse preantral follicles.

Authors:  Kyung Eui Park; Seung-Yup Ku; Kyung Cheon Jung; Hung Ching Liu; Yoon Young Kim; Yong Jin Kim; Seok Hyun Kim; Young Min Choi; Jung Gu Kim; Shin Yong Moon
Journal:  Reprod Sci       Date:  2012-12-13       Impact factor: 3.060

4.  The effect of rLH supplementation to the GnRH-antagonist protocol on endocrine dynamics in the advanced reproductive age.

Authors:  J S Younis; I Izhaki; M Ben-Ami
Journal:  J Endocrinol Invest       Date:  2017-03-13       Impact factor: 4.256

5.  Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.

Authors:  Barbara Sonntag; Ludwig Kiesel; Eberhard Nieschlag; Hermann M Behre
Journal:  J Assist Reprod Genet       Date:  2005-08       Impact factor: 3.412

6.  A cohort study of both human menopausal gonadotropin (HMG) and recombinant luteinizing hormone addition at early follicular stage in in vitro fertilization outcome: A STROBE-compliant study.

Authors:  Xi Xia; Yu Shi; Lan Geng; Dan Liu; Zhenhui Hou; Hongbo Lin; Rong Li; Haiyan Wang; Liyuan Tao; Fanhua Meng; Jian Da; Yun Chen; Jie Qiao; Weiping Qian; Hongzhen Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study.

Authors:  Batool Hosein Rashidi; Roya Kabodmehri; Mamak Shariat; Ensieh Shahrokh Tehraninejad; Alireza Abdollahi; Maryam Bagheri; Fedieh Hagholahi
Journal:  Int J Reprod Biomed       Date:  2019-05-05

Review 8.  A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.

Authors:  Diego Ezcurra; Peter Humaidan
Journal:  Reprod Biol Endocrinol       Date:  2014-10-03       Impact factor: 5.211

9.  Effect of duration of gonadotropin releasing hormone agonist on the outcome of in vitro fertilization-embryo transfer in a short-acting long regimen.

Authors:  Zhen-Ni Mu; Zhen-Gao Sun; Jing-Yan Song; Hong-Gen Liu; Yan Qiao; Qing-Chang Xia
Journal:  Libyan J Med       Date:  2019-12       Impact factor: 1.657

10.  Is it necessary to monitor the serum luteinizing hormone (LH) concentration on the human chorionic gonadotropin (HCG) day among young women during the follicular-phase long protocol? A retrospective cohort study.

Authors:  Wenjuan Zhang; Zhaozhao Liu; Manman Liu; Jiaheng Li; Yichun Guan
Journal:  Reprod Biol Endocrinol       Date:  2022-02-02       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.